The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
Chemical Compound Review

Eletriptan     3-[[(2R)-1-methylpyrrolidin- 2-yl]methyl]-5...

Synonyms: Relpax, eletriptanum, CHEMBL1510, SureCN26719, CHEBI:50922, ...
Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of Relpax


High impact information on Relpax


Chemical compound and disease context of Relpax


Biological context of Relpax


Anatomical context of Relpax


Associations of Relpax with other chemical compounds


Gene context of Relpax


Analytical, diagnostic and therapeutic context of Relpax


  1. Eletriptan vs sumatriptan: a double-blind, placebo-controlled, multiple migraine attack study. Sandrini, G., Färkkilä, M., Burgess, G., Forster, E., Haughie, S. Neurology (2002) [Pubmed]
  2. Eletriptan for the short-term prophylaxis of cluster headache. Zebenholzer, K., Wöber, C., Vigl, M., Wessely, P. Headache. (2004) [Pubmed]
  3. The in vivo pharmacological profile of eletriptan (UK-116,044): a potent and novel 5-HT(1B/1D) receptor agonist. Gupta, P., Butler, P., Shepperson, N.B., McHarg, A. Eur. J. Pharmacol. (2000) [Pubmed]
  4. Craniovascular selectivity of eletriptan and sumatriptan in human isolated blood vessels. MaassenVanDenBrink, A., van den Broek, R.W., de Vries, R., Bogers, A.J., Avezaat, C.J., Saxena, P.R. Neurology (2000) [Pubmed]
  5. Eletriptan in acute migraine: a double-blind, placebo-controlled comparison to sumatriptan. Eletriptan Steering Committee. Goadsby, P.J., Ferrari, M.D., Olesen, J., Stovner, L.J., Senard, J.M., Jackson, N.C., Poole, P.H. Neurology (2000) [Pubmed]
  6. Preference for rizatriptan 10-mg wafer vs. eletriptan 40-mg tablet for acute treatment of migraine. Láinez, M.J., Evers, S., Kinge, E., Allais, G., Allen, C., Rao, N.A., Massaad, R., Lis, K. Cephalalgia : an international journal of headache. (2006) [Pubmed]
  7. Comparative efficacy of eletriptan vs. naratriptan in the acute treatment of migraine. Garcia-Ramos, G., MacGregor, E.A., Hilliard, B., Bordini, C.A., Leston, J., Hettiarachchi, J. Cephalalgia : an international journal of headache. (2003) [Pubmed]
  8. Acute management of migraine: triptans and beyond. Diener, H.C., Limmroth, V. Curr. Opin. Neurol. (1999) [Pubmed]
  9. Eletriptan: a review of its use in the acute treatment of migraine. McCormack, P.L., Keating, G.M. Drugs (2006) [Pubmed]
  10. Effectiveness of eletriptan in acute migraine: primary care for Excedrin nonresponders. Diamond, M.L., Hettiarachchi, J., Hilliard, B., Sands, G., Nett, R. Headache. (2004) [Pubmed]
  11. Pharmacokinetics and safety of oral eletriptan during different phases of the menstrual cycle in healthy volunteers. Shah, A.K., Laboy-Goral, L., Scott, N., Morse, T., Apseloff, G. Journal of clinical pharmacology. (2001) [Pubmed]
  12. Pharmacokinetics, pharmacodynamics, and safety of the 5-HT(1B/1D) agonist eletriptan following intravenous and oral administration. Milton, K.A., Scott, N.R., Allen, M.J., Abel, S., Jenkins, V.C., James, G.C., Rance, D.J., Eve, M.D. Journal of clinical pharmacology. (2002) [Pubmed]
  13. Characterisation of the 5-HT receptor binding profile of eletriptan and kinetics of [3H]eletriptan binding at human 5-HT1B and 5-HT1D receptors. Napier, C., Stewart, M., Melrose, H., Hopkins, B., McHarg, A., Wallis, R. Eur. J. Pharmacol. (1999) [Pubmed]
  14. Triptans induce vasoconstriction of human arteries and veins from the thoracic wall. Wackenfors, A., Jarvius, M., Ingemansson, R., Edvinsson, L., Malmsjö, M. J. Cardiovasc. Pharmacol. (2005) [Pubmed]
  15. Safety and efficacy of eletriptan in the treatment of acute migraine. Takiya, L., Piccininni, L.C., Kamath, V. Pharmacotherapy (2006) [Pubmed]
  16. Hemodynamic and coronary effects of intravenous eletriptan, a 5HT1B/1D-receptor agonist. Muir, D.F., McCann, G.P., Swan, L., Clark, A.L., Hillis, W.S. Clin. Pharmacol. Ther. (1999) [Pubmed]
  17. Effects of eletriptan on the peptidergic innervation of the cerebral dura mater and trigeminal ganglion, and on the expression of c-fos and c-jun in the trigeminal complex of the rat in an experimental migraine model. Knyihár-Csillik, E., Tajti, J., Csillik, A.E., Chadaide, Z., Mihály, A., Vécsei, L. Eur. J. Neurosci. (2000) [Pubmed]
  18. Agonist-directed trafficking explaining the difference between response pattern of naratriptan and sumatriptan in rabbit common carotid artery. Akin, D., Onaran, H.O., Gurdal, H. Br. J. Pharmacol. (2002) [Pubmed]
  19. Priorities for triptan treatment attributes and the implications for selecting an oral triptan for acute migraine: a study of US primary care physicians (the TRIPSTAR Project). Cutrer, F.M., Goadsby, P.J., Ferrari, M.D., Lipton, R.B., Dodick, D.W., McCrory, D., Williams, P. Clinical therapeutics. (2004) [Pubmed]
  20. Current and emerging second-generation triptans in acute migraine therapy: a comparative review. Deleu, D., Hanssens, Y. Journal of clinical pharmacology. (2000) [Pubmed]
  21. Characterisation of the contractile activity of eletriptan at the canine vascular 5-HT1B receptor. Gupta, P., Scatchard, J., Napier, C., McHarg, A., Wallis, R. Eur. J. Pharmacol. (1999) [Pubmed]
  22. Suppression by eletriptan of the activation of trigeminovascular sensory neurons by glyceryl trinitrate. Lambert, G.A., Boers, P.M., Hoskin, K.L., Donaldson, C., Zagami, A.S. Brain Res. (2002) [Pubmed]
  23. Human hepatocytes in primary culture predict lack of cytochrome P-450 3A4 induction by eletriptan in vivo. Pichard-Garcia, L., Hyland, R., Baulieu, J., Fabre, J.M., Milton, A., Maurel, P. Drug Metab. Dispos. (2000) [Pubmed]
  24. Eletriptan metabolism by human hepatic CYP450 enzymes and transport by human P-glycoprotein. Evans, D.C., O'Connor, D., Lake, B.G., Evers, R., Allen, C., Hargreaves, R. Drug Metab. Dispos. (2003) [Pubmed]
  25. Efficacy, safety and tolerability of oral eletriptan in the acute treatment of migraine: results of a phase III, multicentre, placebo-controlled study across three attacks. Stark, R., Dahlöf, C., Haughie, S., Hettiarachchi, J. Cephalalgia : an international journal of headache. (2002) [Pubmed]
WikiGenes - Universities